Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaney L Barratt

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Respiratory Research|June 6, 2017
VEGF isoforms have differential effects on permeability of human pulmonary microvascular endothelial cellsKhadija Ourradi, Thomas Blythe, Caroline Jarrett, et al.
BMJ Open Respiratory Research|September 25, 2025
Differences in disease characteristics and outcomes as determined by biological sex in a large UK idiopathic pulmonary fibrosis population: analysis from the British Thoracic Society, Interstitial Lung Disease registry dataSarah Mulholland, Giles Dixon, Matthew Wells, et al.
Palliative Medicine|March 29, 2025
Interventions to address supportive care needs of people with pulmonary fibrosis and/or their caregivers: A scoping reviewNaa-Dromoh Quarshie, Matthew Wells, Giles Dixon, et al.
Respiratory Research|January 17, 2018
Effects of hypoxia and hyperoxia on the differential expression of VEGF-A isoforms and receptors in Idiopathic Pulmonary Fibrosis (IPF)Shaney L Barratt, Thomas Blythe, Khadija Ourradi, et al.
Respiratory Medicine|February 8, 2018
Physiological predictors of Hypoxic Challenge Testing (HCT) outcomes in Interstitial Lung Disease (ILD)Shaney L Barratt, Jonathon Shaw, Rachel Jones, et al.
Rheumatology Advances in Practice|October 20, 2025
Analysis of the representation of skin tone diversity amongst medical resources illustrating dermatological manifestations of dermatomyositis, systemic sclerosis and vasculitisStacey Kihumba, Giles Dixon, Matthew Wells, et al.
Plos One|April 29, 2021
Krebs von den Lungen 6 (KL-6) as a marker for disease severity and persistent radiological abnormalities following COVID-19 infection at 12 weeksDavid T Arnold, Charmaine Donald, Max Lyon, et al.
Frontiers in Pharmacology|January 9, 2019
South-West of England's Experience of the Safety and Tolerability Pirfenidone and Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)Shaney L Barratt, Sarah Mulholland, Khaled Al Jbour, et al.
Therapeutic Advances in Respiratory Disease|March 15, 2026
Validation of pre-flight algorithms in predicting hypoxic challenge testing (HCT) outcomes in interstitial lung disease (ILD)Cameron Bonthrone, Beyazit Durdu, Sarah Mulholland, et al.
Rheumatology Advances in Practice|April 14, 2026
Pulmonary cystic destruction in systemic sclerosis and antisynthetase syndrome associated non-specific interstitial pneumonitis: a case series of a novel radiological phenotypeMatthew Wells, Giles Dixon, Nidhi Bhatt, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Respiratory Research|June 6, 2017
VEGF isoforms have differential effects on permeability of human pulmonary microvascular endothelial cellsKhadija Ourradi, Thomas Blythe, Caroline Jarrett, et al.
BMJ Open Respiratory Research|September 25, 2025
Differences in disease characteristics and outcomes as determined by biological sex in a large UK idiopathic pulmonary fibrosis population: analysis from the British Thoracic Society, Interstitial Lung Disease registry dataSarah Mulholland, Giles Dixon, Matthew Wells, et al.
Palliative Medicine|March 29, 2025
Interventions to address supportive care needs of people with pulmonary fibrosis and/or their caregivers: A scoping reviewNaa-Dromoh Quarshie, Matthew Wells, Giles Dixon, et al.
Respiratory Research|January 17, 2018
Effects of hypoxia and hyperoxia on the differential expression of VEGF-A isoforms and receptors in Idiopathic Pulmonary Fibrosis (IPF)Shaney L Barratt, Thomas Blythe, Khadija Ourradi, et al.
Respiratory Medicine|February 8, 2018
Physiological predictors of Hypoxic Challenge Testing (HCT) outcomes in Interstitial Lung Disease (ILD)Shaney L Barratt, Jonathon Shaw, Rachel Jones, et al.
Rheumatology Advances in Practice|October 20, 2025
Analysis of the representation of skin tone diversity amongst medical resources illustrating dermatological manifestations of dermatomyositis, systemic sclerosis and vasculitisStacey Kihumba, Giles Dixon, Matthew Wells, et al.
Plos One|April 29, 2021
Krebs von den Lungen 6 (KL-6) as a marker for disease severity and persistent radiological abnormalities following COVID-19 infection at 12 weeksDavid T Arnold, Charmaine Donald, Max Lyon, et al.
Frontiers in Pharmacology|January 9, 2019
South-West of England's Experience of the Safety and Tolerability Pirfenidone and Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)Shaney L Barratt, Sarah Mulholland, Khaled Al Jbour, et al.
Therapeutic Advances in Respiratory Disease|March 15, 2026
Validation of pre-flight algorithms in predicting hypoxic challenge testing (HCT) outcomes in interstitial lung disease (ILD)Cameron Bonthrone, Beyazit Durdu, Sarah Mulholland, et al.
Rheumatology Advances in Practice|April 14, 2026
Pulmonary cystic destruction in systemic sclerosis and antisynthetase syndrome associated non-specific interstitial pneumonitis: a case series of a novel radiological phenotypeMatthew Wells, Giles Dixon, Nidhi Bhatt, et al.
Pageof 5